Speaker illustration

Doctor Sander van Doorn

University Medical Center Utrecht, Utrecht (Netherlands (The))

Member of:

European Society of Cardiology

Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation

Event: EHRA 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation: clinical 1

Thumbnail

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial

Event: EHRA 2024

Topic: Oral Anticoagulation

Session: Atrial fibrillation: treatment 1

Thumbnail

Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomized trial in general practice

Event: EuroPrevent 2018

Topic: Atrial Fibrillation, Other

Session: Moderated Poster Session IV

Thumbnail

Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis

Event: EuroPrevent 2018

Topic: Atrial Fibrillation, Other

Session: Arrhythmias and device therapy

Thumbnail